FDA Barrier Leader The company has developed the world’s only FDA cleared viral barrier for ultrasound procedures, providing a strong infection control differentiator for buyers in hospitals and imaging centers. The sales opportunity is to pitch this barrier to infection control committees and radiology departments, and to bundle it with compatible products such as ultrasound probe covers and gels to simplify procurement.

US Manufacturing Strength Most products are manufactured in the United States with key production in Morgan Hill. This domestic emphasis supports reliable lead times and on site quality control, a compelling message for procurement teams that prefer local sourcing and reduced supply chain risk. It also positions the company well for customers with regulatory or purchaser preferences for domestically made medical supplies.

One Stop Infection Control The product portfolio covers ultrasound probe covers, FDA cleared viral barriers, adhesives, needle guides kits, ultrasound gel, and storage or transport covers. This breadth enables the company to be a single supplier for imaging department infection control needs, facilitating bundled pricing and a simpler procurement process for hospitals and clinics.

Growth Through Partnerships With ecommerce capabilities and a focused medical device portfolio, there are opportunities to expand through distribution networks, group purchasing organizations, and collaborations with ultrasound equipment manufacturers. Partnership driven selling can extend reach to hospitals, clinics, and ambulatory centers while enabling bundled offerings and streamlined procurement.

Innovation and Clinical Value Continued emphasis on advancing ultrasound procedure safety positions the company to engage clinical decision makers focused on patient safety and procedure efficiency. The value proposition includes reducing infection risk and improving workflow, which aligns with more stringent infection control standards and value based care initiatives.